24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
22.03.2012
- Watson Pharmaceuticals Inc is close to buying Swiss-based Actavis for around $7 billion, marking the latest deal between generics companies racing to achieve economies of scale...
22.03.2012
- GlaxoSmithKline and rivals including Pfizer are preparing second-round bids for Turkey's Mustafa Nevzat Ilac Sanayi, a maker of injectable generic drugs, that may be worth as much...
